Filtra per genere

A-Level Capital Podcast

A-Level Capital Podcast

Student-run VC at Johns Hopkins University

A podcast dedicated to meaningful conversations with founders and investors on all things startups and venture capital. Our guests take us inside the world of tech and innovation, from industry trends to leadership principles. We also get lots of valuable career advice, especially geared toward young professionals interested in breaking into venture and entrepreneurship. This podcast is entirely student-run and brought to you by A-Level Capital, a VC fund managed by undergraduates at Johns Hopkins University that invests in Hopkins entrepreneurs. To learn more, visit www.alevelcapital.com.

7 - Founder + Investor Series: Halle Tecco on Building and Investing in Digital Health
0:00 / 0:00
1x
  • 7 - Founder + Investor Series: Halle Tecco on Building and Investing in Digital Health

    Our guest this week is Halle Tecco. Halle has been building and investing at the forefront of digital health for over a decade. She is the co-founder of Cofertility (reshaping egg donation and egg freezing), Natalist (acquired by Everly Health), and digital health venture fund Rock Health. She is also an Adjunct Professor at Columbia Business School, where she teaches the school’s first MBA-level course on digital health investing, and hosts The Heart of Healthcare podcast.


    In this episode, we cover:

    The evolution of digital health How to remain a healthcare optimist in today's environment Who has benefited most from digital health innovations … and who has been left behind Whitespace and opportunity in women’s health, especially fertility care Co-founding Cofertility


    Halle on LinkedIn: https://www.linkedin.com/in/halletecco/

    Cofertility: https://www.cofertility.com/

    The Heart of Healthcare: https://www.heartofhealthcarepodcast.com/

    Blog post, Defining Women’s Health: https://www.hbs.edu/healthcare/blog/post/defining-womens-health-womens-health-is-more-than-female-anatomy-and-our-reproductive-systemits-about-unraveling-centuries-of-inequities-due-to-living-in-a-patriarchal-healthcare-system

    Blog post, Why Fertility Care is Broken: https://fortune.com/2022/04/28/reasons-why-fertility-care-broken-cost-access-outcome-women-health-halle-tecco/


    To stay updated on all things A-Level Capital: https://www.linkedin.com/company/a-level-capital/

    Tue, 25 Jul 2023 - 37min
  • 6 - Investor Series: Merrill Anovick (25m Health) on Incubating and Investing in Health-Tech Companies

    Our guest this week is Merrill Anovick. Merrill is the President and COO of 25m Health, a health-tech venture studio founded in partnership with Lifepoint Health that backs startups aimed at enhancing the delivery of high-quality healthcare.


    This episode dives deep into the venture studio model of investing + incubating. We cover:

    the difference between a venture platform and a more traditional VC firm where venture studios can add the most value how 25 Madison and 25m Health think about mitigating risk and validating potential incubation opportunities the decision to incubate vs invest some of the challenges faced by health-tech entrepreneurs if there is a ‘formula’ for successfully launching companies

    ... and much more!


    Merrill on LinkedIn: https://www.linkedin.com/in/merrillanovick/

    25m Health: https://www.25madison.com/health


    To stay updated: https://www.linkedin.com/company/a-level-capital/

    Wed, 28 Jun 2023 - 47min
  • 5 - Investor Series: Morgan Cheatham (Bessemer Ventures) on Predictions for Healthcare & Life Sciences

    Our guest this week is Morgan Cheatham. Morgan is a VP at Bessemer Venture Partners in the healthcare and life sciences group. He’s simultaneously pursuing medical training at Brown University … and in case that wasn’t enough, is active on Twitter (@morgancheatham) and Substack (@ Decoding Tech Bio). 

    Morgan is an absolute wealth of knowledge on all things bio. We cover lots of ground, including AI applications in healthcare, techbio, value-based care, direct-to-clinician distribution models, and balancing investing with medical school. We hope you enjoy (and take notes)! 

    Morgan on LinkedIn: https://www.linkedin.com/in/morgancheatham/

    Morgan on Twitter: @morgancheatham

    Morgan on Substack: https://decodingbio.substack.com/


    To stay updated: 

    A-Level Capital LinkedIn: https://www.linkedin.com/company/a-level-capital/

    To reach out to the A-Level Capital Pod with feedback or suggestions, please email jemina@alevelcapital.com and anusha@alevelcapital.com

    Tue, 07 Mar 2023 - 53min
  • 4 - Founder Series: Robin Shah (Thyme Care, OneOncology, Flatiron Health) on Transforming the Cancer Patient Care Journey

    Our guest this week is Robin Shah, founder and CEO of Thyme Care. Robin has spent his entire professional career in digital health, working toward one primary goal: to improve the cancer patient care journey. Before founding Thyme Care, he was among the first employees and VP of Marketing at Flatiron Health (acquired by Roche), then joined the founding team at OneOncology ($200M in funding, backed by General Atlantic). Today, Thyme guides cancer patients through a complex healthcare system by providing personalized support, quality resources, and quick access to high-value care. They’ve raised $22M from firms like Andreessen Horowitz and Bessemer. 


    Robin on LinkedIn: https://www.linkedin.com/in/robin-shah-8072bb35/

    Thyme Care: https://www.thymecare.com/


    To stay updated: 

    A-Level Capital LinkedIn: https://www.linkedin.com/company/a-level-capital/

    To reach out to the A-Level Capital Pod with feedback or suggestions, please email jemina@alevelcapital.com and anusha@alevelcapital.com

    Tue, 21 Feb 2023 - 38min
  • 3 - Investor Series: Dr. Hesam Motlagh (Khosla Ventures) on Investing in Breakthrough Technologies

    Our guest this week is Dr. Hesam Motlagh. Hesam is an investment partner at Khosla Ventures, a VC firm that backs bold, innovative companies leveraging technology to solve today’s most pressing problems. Founded in 2004, their portfolio includes OpenAI, InstaCart, Affirm, and Impossible Foods. 

    At KV, Hesam focuses on companies that translate basic science into products that impact and improve society. He is also Chief of Staff to the legendary Vinod Khosla, co-founder of Sun Microsystems and founding partner of KV. We speak with Hesam about his journey into investing from academia, the mission behind KV, and how they live up to their thesis of being bold, early, and impactful.

    Hesam on LinkedIn: https://www.linkedin.com/in/hesam-motlagh-1a379663/

    Khosla Ventures: https://www.khoslaventures.com/

    Resources: The Power Law (Sebastian Mallaby); Vinod Khosla: 70-80% Of VCs Add Negative Value To Startups (TechCrunch), The Entrepreneurial Roller Coaster by Khosla Ventures (Khosla Ventures), A few Critical Climate Technology Breakthroughs Multiplied by “Instigators” is desperately needed (Vinod Khosla)


    Stay updated:

    A-Level Capital LinkedIn: https://www.linkedin.com/company/a-level-capital/

    To reach out to the A-Level Capital Pod with feedback or suggestions, please email jemina@alevelcapital.com and anusha@alevelcapital.com


    Tue, 14 Feb 2023 - 44min
Mostra altri episodi